Thousands of people in England who are at higher risk of esophageal cancer could soon be offered a seven-minute test on the National Health Service that involves swallowing a small capsule on a string. The National Institute for Health and Care Excellence, known as Nice, put the recommendation forward in new draft guidance, according to the Cambridge News and The Independent.
The test checks for Barrett's esophagus, a condition in which stomach acid damages the lining of the food pipe. Some of the affected cells can grow abnormally and may develop into cancer. Nice has recommended two tests for NHS use: Cytosponge and EndoSign.
The patient swallows a capsule attached to a string. The capsule dissolves in the stomach and leaves a small sponge behind. After a few minutes, the sponge is pulled back up by the string, and it collects cells from the lining of the esophagus on the way. A laboratory then analyzes those cells. The whole procedure takes about seven minutes.
The technology does not require sedation. It can be carried out in GP practices, pharmacies and community diagnostic centers, and it has been tested in pilot schemes. Nice said its committee found that patients prefer the sponge test to an endoscopy, in which a thin tube with a camera is passed through the throat.
More than 9,000 people a year are diagnosed with esophageal cancer in the UK, and it is often found late, when it is harder to treat. Nice says Barrett's esophagus affects around 1% to 2% of adults and is common among people who have long-term acid reflux. Most people with the condition do not go on to develop cancer, but the tests give them a way to monitor it.
For patients with persistent acid reflux and other risk factors, a quick test in a local setting could make checking for changes easier than a hospital endoscopy. Nice said the tests help identify who needs further tests and treatment. The health service also expects to focus its endoscopy capacity on the people who need it most.
Professor Jonathan Benger, Nice's chief executive, said finding the cancer sooner is important because it is very difficult to treat at a later stage. He described the capsule sponge tests as a quick and less invasive way to detect concerning changes.
Professor Peter Johnson, national clinical director for cancer at NHS England, said thousands of people have already benefited from the test through pilots. He said an easier way to check the lining of the esophagus could reduce the need for more complicated endoscopy tests and help the NHS free up resources to find cancers earlier.
The recommendation is the first issued by Nice under the National HealthTech Access Programme, an initiative designed to identify cutting-edge technology and devices and assess whether the health service should use them routinely. Thomas Slater, Nice's director of healthtech, called it an important milestone. He said the aim is for high-impact technologies to be adopted consistently across the country, delivering benefits for patients and value for taxpayers.
Because the guidance is still in draft form, the tests are not yet in routine use across the NHS. Nice said the tests could be offered to thousands of people at higher risk of esophageal cancer.
Around Prague, based on reporting by Cambridge News, The Independent